How much is a box of Acemini’s latest price in 2024?

Asciminib (Asciminib) is a new third-generation tyrosine kinase inhibitor (TKI), mainly used to treat chronic myelogenous leukemia (CML). It prevents the proliferation of cancer cells by inhibiting the abnormal protein activity caused by BCR-ABL1 gene mutation. Unlike traditional TKI drugs, acemini acts on ABL1kinasemyristoyl The pan>binding pocket enables it to suppress mutations that are resistant to first- and second-generation TKIs, especially the T315I mutation. This innovative mechanism makes aceminib an important treatment option for patients with drug-resistant CML.

Aximini has shown promising efficacy in clinical trials, particularly in patients who have failed multipleTKI treatments. Its side effects are relatively mild, and common ones include fatigue, nausea, headache, etc. Compared with earlier TKI drugs, aceminib provides better ability to respond to drug-resistant mutations, giving more patients a chance of long-term remission.

In terms of price, Assimini is not currently available in the country, so domestic patients cannot purchase it directly and usually need to obtain it through overseas channels. Overseas, Asiminib is divided into two options: original drug and generic drug. The original drugs are mainly European versions and are very expensive. A box usually costs tens of thousands of yuan, which is a huge financial burden for many patients. Generic drugs are mainly from Laos and are relatively cheap, about more than 4,000 yuan per box. Although there is a huge price difference, the ingredients of generic drugs in Laos are basically the same as those of the original drugs, and their therapeutic effects are quite reliable, so they have become the choice of many patients.

Overall, aceminib provides a new treatment avenue for CML patients, especially for those who have failed treatment with previous generations of TKI drugs.